Publications by authors named "Lingcui Xie"
Objective: To investigate the impact of COVID-19 infection on maternal and neonatal outcomes and immunity in pregnant women in China.
Methods: 283 pregnant women with COVID-19 were included in the prospective observational cohort study and divided into five groups based on infection stage. Antibody levels were measured in plasma, umbilical cord blood, and breast milk, and combined with clinical data and 6-month follow-up results.
Article Synopsis
- Scientists studied how the area around ovarian cancer cells, called the tumor microenvironment (TME), affects how well chemotherapy works.
- They looked at different types of cells in the TME to see how they communicate and influence each other during treatment.
- The results showed that some cells in the TME can help cancer resist chemotherapy, while others can make it easier for the treatment to work, suggesting that changing the TME might improve chemotherapy for ovarian cancer patients.
Platinum-based chemotherapy is the standard postoperative adjuvant treatment for ovarian cancer (OC). Despite the initial response to chemotherapy, 85% of advanced OC patients will have recurrent disease. Relapsed disease and platinum resistance are the major causes of death in OC patients.
View Article and Find Full Text PDF